Coinbase to Acquire Deribit in a $2.9 Billion Deal

Published 1 hours agoCOIN

Coinbase to Acquire Deribit in a $2.9 Billion Deal

Coinbase has announced its intention to acquire Deribit, a leader in cryptocurrency derivatives, for a total of $2.9 billion. The deal includes $700 million in cash and 11 million shares of Coinbase Class A common stock. Reuters reported this strategic acquisition is designed to strengthen Coinbase's position by broadening its offerings to include derivatives like futures and options, alongside its existing spot trading services.

Deribit currently holds the title of the world’s largest crypto derivatives exchange, boasting over $1 trillion in trading volume last year, according to the Financial Times. This acquisition fits into the growing trend of mergers and acquisitions within the industry, largely catalyzed by U.S. President Donald Trump's supportive cryptocurrency policies which aim to position the United States as a leading global crypto hub.

The completion of the acquisition is contingent on regulatory approval and is expected by the end of the year. Reports indicate that following the announcement, shares of Coinbase increased nearly 5% during pre-market trading. As of the latest trading figures, Coinbase shares are priced at $209.105, experiencing a slight rise from the previous day within active intraday trading conditions.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Nu Skin to Launch Prysm iO™, Projects Strong 2025 Revenue

Nu Skin to Launch Prysm iO™, Projects Strong 2025 Revenue

11 minutes agoNUS

Nu Skin Enterprises is set to launch its new intelligent wellness device, Prysm iO™, later this year. The company aims for this launch to bolster growth in its nutrition segment, a strategic move expected to attract more consumers and enhance its market presence. This announcement was highlighted by investing.com, which showcased the company's efforts to innovate within its product offerings. In addition, Nu Skin provided revenue projections for 2025, with expectations to generate between $345 million and $365 million in the first quarter. For the entire year, the company targets a revenue range of $1.48 billion to $1.62 billion. Following this optimistic forecast, shares of Nu Skin surged by 16.2%, reflecting market confidence in the company's financial health and strategic planning. Nu Skin has expressed a focus on strengthening its core business activities and expanding in emerging markets, particularly in Latin America. Moreover, the company anticipates adjusted earnings per share between $0.90 and $1.30 for 2025, not accounting for gains from the sale of Mavely, according to nasdaq.com. These initiatives underscore Nu Skin's commitment to enhancing both its product offerings and overall financial performance.

McKesson Maintains Steady Course with Medical-Surgical Supply Segment

McKesson Maintains Steady Course with Medical-Surgical Supply Segment

26 minutes agoMCK

As of May 8, 2025, there is no current indication that McKesson Corporation intends to spin off its medical-surgical supply business. The last major transaction involving this segment dates back to October 2006, when McKesson sold its acute-care medical and surgical supply distribution business to Owens & Minor, Inc. Despite a lack of recent spin-off plans, McKesson's Medical-Surgical Solutions segment continues operations, servicing a range of healthcare facilities with medical supplies and solutions. Notably, in March 2023, McKesson Medical-Surgical Government Solutions secured a five-year U.S. Department of Veterans Affairs Federal Supply Schedule contract. This development highlights McKesson's active role in the healthcare supply chain. Overall, McKesson appears to be integrating its medical-surgical supply business within its larger operational structure, as no recent announcements have been made about separating this segment. The company's focus remains on leveraging its strengths to maintain its position in the healthcare industry.

Occidental Petroleum Sets Ambitious Cost-Cutting Goals for 2025

Occidental Petroleum Sets Ambitious Cost-Cutting Goals for 2025

41 minutes agoOXY

Occidental Petroleum has announced a comprehensive plan to save $350 million by 2025, focusing on boosting efficiency across its operations. A significant component of this plan includes a targeted 7% decrease in drilling and completion costs, aimed to build on a 12% boost achieved in 2024, translating to approximately $100 million in savings. Efficiency improvements are taking center stage in the company's cost reduction strategy, as detailed by Fool.com. Supporting these efforts, synergies realized through the integration with CrownRock are expected to lower well costs by more than $1 million per well. Moreover, supply chain optimization is projected to yield nearly $10 million in savings just from water integration alone during the first quarter of 2025. The company is also investing in artificial intelligence technologies to further streamline operations by enhancing predictive maintenance and optimizing drilling locations, according to Financial Beings. In addition to operational improvements, Occidental Petroleum is reinforcing its balance sheet, as evidenced by a achieved $4.5 billion debt repayment goal, alongside plans to divest $1.2 billion in assets in early 2025. These measures reflect the company’s commitment to bolstering financial performance through strategic cost management and operational efficiency.

Affirm's Stock Falls 8% Despite Beating Earnings Expectations

Affirm's Stock Falls 8% Despite Beating Earnings Expectations

56 minutes agoAFRM

Affirm Holdings Inc. recently reported an unexpected net profit for its fiscal second-quarter 2025, defying analysts' predictions of a loss. The company posted a profit of 23 cents per share, a result that pleasantly surprised market watchers. Despite this strong performance, the company's stock fell by 8% following the earnings announcement. The company's financial health appeared robust with revenue increasing by 46.6% from the previous year, reaching $866 million. Furthermore, Affirm's Gross Merchandise Volume (GMV) climbed 32% to $7.2 billion, as consumers continue to embrace the buy-now-pay-later model. As detailed by Kiplinger, these figures underscore the company's ability to grow its revenue significantly and handle a large volume of transactions on its platform. Affirm's guidance for the upcoming fiscal quarter projects revenue in the range of $640 million to $670 million, outperforming analyst expectations. This information was highlighted by Investopedia, which reported that, despite the company's positive financial results and forecasts, the stock market's reaction might reflect apprehensions about future growth prospects and broader economic conditions.